Legislature(2023 - 2024)ADAMS 519
04/29/2024 01:30 PM House FINANCE
Note: the audio ![]()
and video ![]()
recordings are distinct records and are obtained from different sources. As such there may be key differences between the two. The audio recordings are captured by our records offices as the official record of the meeting and will have more accurate timestamps. Use the icons to switch between them.
| Audio | Topic |
|---|---|
| Start | |
| HB202 | |
| Adjourn |
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+ teleconferenced
= bill was previously heard/scheduled
| += | HB 202 | TELECONFERENCED | |
| += | HB 260 | TELECONFERENCED | |
| += | HB 307 | TELECONFERENCED | |
| + | TELECONFERENCED | ||
| += | HB 122 | TELECONFERENCED | |
HOUSE FINANCE COMMITTEE
April 29, 2024
4:50 p.m.
4:50:18 PM
CALL TO ORDER
Co-Chair Foster called the House Finance Committee meeting
to order at 4:50 p.m.
MEMBERS PRESENT
Representative Neal Foster, Co-Chair
Representative DeLena Johnson, Co-Chair
Representative Julie Coulombe
Representative Mike Cronk
Representative Alyse Galvin
Representative Sara Hannan
Representative Andy Josephson
Representative Dan Ortiz
Representative Will Stapp
Representative Frank Tomaszewski
MEMBERS ABSENT
Representative Bryce Edgmon, Co-Chair
ALSO PRESENT
Courtney Enright, Legislative Liaison, Department of
Health; Savaya Bieber, Staff, Representative DeLena
Johnson.
PRESENT VIA TELECONFERENCE
Kelly Manning, Deputy Director, Division of Innovation and
Education Excellence, Department of Education and Early
Development.
SUMMARY
HB 202 OPIOID OVERDOSE DRUGS IN SCHOOLS
CSHB 202(EDC) was REPORTED out of committee with
eight "do pass" recommendations and with two "no
recommendation" recommendations and with one new
fiscal impact note from the Department of Health
and one previously published fiscal impact note:
FN1 (EED).
HB 260 CATASTROPHIC ILLNESS/MEDICAL ASSISTANCE
HB 260 was SCHEDULED but not HEARD.
HB 307 INTEGRATED TRANSMISSION SYSTEMS
HB 307 was SCHEDULED but not HEARD.
Co-Chair Foster reviewed the meeting agenda. He set an
amendment deadline for HB 122 of May 1, 2024, at 5:00 p.m.
HOUSE BILL NO. 202
"An Act relating to the availability and
administration of opioid overdose drugs in public
schools."
4:52:30 PM
Co-Chair Foster asked the sponsor to provide a quick
summary of the bill.
Co-Chair Johnson explained that the bill would require all
school districts to make available at least two opioid
overdose drug kits in each main school building. The bill
would also ensure that at least one person who was trained
to administer the overdose kit would be present during all
hours the main school building was open. The Department of
Health (DOH) would be required to provide each school
district with the kit and the commissioner would provide a
short video to each school district explaining how to
administer the kit.
4:54:21 PM
AT EASE
4:54:31 PM
RECONVENED
Co-Chair Foster noted that a representative from the
Department of Education and Early Development (DEED) would
be speaking to the fiscal note.
4:54:52 PM
KELLY MANNING, DEPUTY DIRECTOR, DIVISION OF INNOVATION AND
EDUCATION EXCELLENCE, DEPARTMENT OF EDUCATION AND EARLY
DEVELOPMENT, JUNEAU (via teleconference), stated that DEED
prepared one zero fiscal impact note with the control code
UUmii. She explained that the reason for the zero fiscal
impact was because the requirements for the department were
already in place and it already had a course in the
administration of Naloxone, which was the most common
opioid overdose reversal drug. The course was developed in
collaboration with DOH and was available online. She added
that the other requirements would only impact DOH.
4:56:23 PM
COURTNEY ENRIGHT, LEGISLATIVE LIAISON, DEPARTMENT OF
HEALTH, reviewed the fiscal note by DOH with the control
code OdJTe. She explained that the department projected
that there would be a cost of about $67,800 in the first
year of the bill's implementation to fund the necessary
startup costs and $42,000 every following third year.
Representative Hannan emphasized that she supported the
bill and thought it was important to move it forward. She
thought it appeared that DOH would provide supplies to
schools beginning in FY 25 and it was not anticipated that
the department would need to provide supplies again until
the kits expired three years later. She asked if DOH was in
a position to restock the supplies if a school used both
doses of Naloxone.
Ms. Enright responded that the department believed it would
be able to restock when necessary. She explained that DOH
contemplated whether to include the restocking costs in the
fiscal note, but there were not enough data points to
provide an accurate projection.
Representative Hannan commented that she anticipated that
the program would succeed. She did not think that the
legislature should waiver from ensuring that doses of the
reversal drugs were broadly available. The only way the
bill would succeed was if it was broadly implemented. She
thought that following initial implementation and training,
there would be an increase in the use of Naloxone and a
decrease in overdose deaths in the state. She stressed that
the cost of the reversal drug would result in saving lives.
Co-Chair Foster appreciated the bill and relayed there were
some villages in the state that might have Naloxone
available in health clinics, but other villages might not
have it available. The bill might be the only source for
the lifesaving aid in an entire village.
4:59:21 PM
Representative Galvin indicated that she was concerned that
there would only be two doses per school. She understood
that when a drug infiltrated a village, it became an
epidemic. She recalled that there were four fentanyl
overdoses in a single school in Anchorage. She asked how
the decision was made to provide two doses.
Ms. Enright replied that the bill specified that there
would be two doses per school.
Representative Galvin asked if there was any data that
suggested that it would make sense to provide more than two
doses.
Co-Chair Johnson noted that although the bill indicated
that there would be two doses in each school, there would
actually be four doses. She stated that the information
needed to be updated.
Representative Galvin understood that there would actually
be four doses provided to each school as opposed to the two
doses stated in the bill.
Co-Chair Johnson responded that there needed to be an
amendment to increase the number to four, but that the
fiscal note reflected the cost of providing four doses.
Representative Tomaszewski asked about the fiscal note from
DEED, which stated that all school bus drivers were
required to be trained to administer Naloxone. He asked if
there would be doses on each bus.
Co-Chair Johnson replied that the bill needed to be updated
because the school bus driver requirement was removed from
the bill in the House Education Committee. She explained
that Naloxone was not necessarily effective after it had
been frozen and school buses were often cold.
SAVAYA BIEBER, STAFF, CO-CHAIR DELENA JOHNSON, explained
that the fiscal note reflected the cost of two overdose
kits and there were two doses of Naloxone in each overdose
kit, meaning there were four doses altogether.
Representative Ortiz asked if there had been public
testimony on the bill.
Co-Chair Foster responded in the affirmative.
5:03:51 PM
Representative Stapp MOVED to REPORT CSHB 202(EDC) out of
committee with individual recommendations and the
accompanying fiscal notes. There being NO OBJECTION, it was
so ordered.
CSHB 202(EDC) was REPORTED out of committee with eight "do
pass" recommendations and with two "no recommendation"
recommendations and with one new fiscal impact note from
the Department of Health and one previously published
fiscal impact note: FN1 (EED).
5:04:33 PM
Co-Chair Foster explained that the meeting would be
recessed until 9:00 a.m. on April 30, 2024. He reviewed the
agenda for the morning meeting.
ADJOURNMENT
5:05:34 PM
The meeting was adjourned at 5:05 p.m.
| Document Name | Date/Time | Subjects |
|---|---|---|
| HB 202 Public Testimony Rec'd by 042424.pdf |
HFIN 4/29/2024 1:30:00 PM |
HB 202 |
| HB202 Letter of Support ACT 2024.4.22 .pdf |
HFIN 4/29/2024 1:30:00 PM |
HB 202 |
| HB 307 RRC HFin Presentation 4.29.24.pdf |
HFIN 4/29/2024 1:30:00 PM |
HB 307 |